Financial Analysis: Cencora (NYSE:COR) versus Cannlabs (OTCMKTS:CANL)

Cannlabs (OTCMKTS:CANL) and Cencora (NYSE:COR) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, profitability, risk, analyst recommendations, institutional ownership, dividends and earnings.

Profitability

This table compares Cannlabs and Cencora’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Cannlabs	N/A	N/A	N/A
Cencora	0.78%	135.20%	4.20%

Volatility and Risk

Cannlabs has a beta of 1.53, indicating that its stock price is 53% more volatile than the S&P 500. Comparatively, Cencora has a beta of 0.59, indicating that its stock price is 41% less volatile than the S&P 500.

Valuation and Earnings

This table compares Cannlabs and Cencora”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cannlabs	N/A	N/A	N/A	N/A	N/A
Cencora	$321.33 billion	0.17	$1.55 billion	$13.04	21.41

Cencora has higher revenue and earnings than Cannlabs.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Cannlabs and Cencora, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cannlabs	0	0	0	0	0.00
Cencora	0	3	12	0	2.80

Cencora has a consensus target price of $380.25, indicating a potential upside of 36.22%. Given Cencora’s stronger consensus rating and higher probable upside, analysts plainly believe Cencora is more favorable than Cannlabs.

Institutional and Insider Ownership

97.5% of Cencora shares are owned by institutional investors. 0.4% of Cencora shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Cencora beats Cannlabs on 9 of the 10 factors compared between the two stocks.

About Cannlabs

CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. was incorporated in 2010 and is based in Denver, Colorado.

About Cencora

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.